A study published in the European Heart Journal on Feb. 18 suggests healthcare expenditures in Europe would skyrocket if local systems adopted experts’ latest guidelines for cholesterol-lowering treatment.

Women who have suffered domestic abuse are 31% more likely to develop heart disease and 51% more likely to develop type 2 diabetes than women who haven’t been abused, a study out of the U.K. has found.

Many Americans who can’t afford prescription insulin for their diabetes are turning to unregulated, illegal markets for discounted products, researchers reported in JAMA Internal Medicine this month.

Some 20% of children have high blood pressure, WBAL-TV reported Feb. 17.

As the world waits and watches to see what the coronavirus does next, the bad old flu is getting a second wind in the U.S.—and children may be bearing the brunt.

Stroke survivors who are optimistic about their recovery demonstrate lower levels of inflammation and physical disability than their less-cheerful counterparts, researchers reported at the Nursing Symposium of the American Stroke Association’s International Stroke Conference.

A 92.6% reduction in the list price of tafamidis—an effective but ultimately unaffordable drug designed to treat transthyretin amyloid cardiomyopathy—would be required to make the medication accessible to the average heart patient, researchers reported in Circulation Feb. 12.

“This pioneering effort leverages evidence-based guidelines and the consensus of medical experts in a new and powerful way to optimize care for military veterans,” said Theodore L. DeWeese, MD, chair of ASTRO's board.